These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26998255)

  • 41. Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations.
    Nash A; Birch HL; de Leeuw NH
    J Biomol Struct Dyn; 2017 Feb; 35(3):564-573. PubMed ID: 26886688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity.
    Cerofolini L; Amar S; Lauer JL; Martelli T; Fragai M; Luchinat C; Fields GB
    Sci Rep; 2016 Jul; 6():29511. PubMed ID: 27405411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function.
    Grossman M; Tworowski D; Dym O; Lee MH; Levy Y; Murphy G; Sagi I
    Biochemistry; 2010 Jul; 49(29):6184-92. PubMed ID: 20545310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.
    Jiang B; Zhang Y; Liu J; Tsigkou A; Rapti M; Lee MH
    Oncotarget; 2017 Apr; 8(14):22685-22699. PubMed ID: 28186971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Virtual screening and molecular simulations of antisense peptides targeting MT1-MMP].
    Zeng L; Tan B; Yang Y; Qiu J; Xiong L; Mao C
    Sheng Wu Gong Cheng Xue Bao; 2015 Feb; 31(2):269-80. PubMed ID: 26062348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of flexibility of the α2 chain of type I collagen on collagenase cleavage.
    Mekkat A; Poppleton E; An B; Visse R; Nagase H; Kaplan DL; Brodsky B; Lin YS
    J Struct Biol; 2018 Sep; 203(3):247-254. PubMed ID: 29763735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.
    Monaco S; Sparano V; Gioia M; Sbardella D; Di Pierro D; Marini S; Coletta M
    Protein Sci; 2006 Dec; 15(12):2805-15. PubMed ID: 17088321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of the Early Catalytic Events in the Collagenolysis by Matrix Metalloproteinase-1.
    Waheed SO; Varghese A; DiCastri I; Kaski B; LaRouche C; Fields GB; Karabencheva-Christova TG
    Chemphyschem; 2023 Feb; 24(3):e202200943. PubMed ID: 36723036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tricine as a convenient scaffold for the synthesis of
    Stawikowski MJ; Fields GB
    Tetrahedron Lett; 2018 Jan; 59(2):130-134. PubMed ID: 29545652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Insights into the Catalytic Mechanism of Collagenolysis by Zn(II)-Dependent Matrix Metalloproteinase-1.
    Gorantla KR; Krishnan A; Waheed SO; Varghese A; DiCastri I; LaRouche C; Paik M; Fields GB; Karabencheva-Christova TG
    Biochemistry; 2024 Aug; 63(15):1925-1940. PubMed ID: 38963231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.
    Radzki D; Negri A; Kusiak A; Obuchowski M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Traditional Uses, Phytochemical Constituents and Ethnopharmacological Properties of Mistletoe from Phoradendron and Viscum Species.
    Montoya-Inzunza LA; Heredia JB; Patra JK; Gouda S; Kerry RG; Das G; Gutierrez-Grijalva EP
    Comb Chem High Throughput Screen; 2024; 27(8):1093-1110. PubMed ID: 37622692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Dynamics Simulations of Matrix Metalloproteinase 13 and the Analysis of the Specificity Loop and the S1'-Site.
    Choi JY; Chung E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.
    Christopoulou ME; Papakonstantinou E; Stolz D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.